Abstract
Allergic rhinitis (AR) is considered to be multifactorial inflammatory diseases involving complex interactions between genetic and environmental influences. Inflammatory reactions in AR are regulated by many cytokines. The impact of genetic factors on the pathogenesis of AR is currently an area of intense investigation. Various loci and candidate genes have been suggested to underlie allergy. Many or all are still controversial. No significant evidence for linkage to AR has been shown so far, although significant evidence for linkage to various allergic diseases. The aim of this review was to investigate whether the genetic polymorphisms were associated with AR in the literature.
Keywords: Allergic rhinitis, genetic, polymorphism
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: Genetic Polymorphism in Allergic Rhinitis
Volume: 7 Issue: 1
Author(s): Yusuf Vayisoglu and Murat Unal
Affiliation:
Keywords: Allergic rhinitis, genetic, polymorphism
Abstract: Allergic rhinitis (AR) is considered to be multifactorial inflammatory diseases involving complex interactions between genetic and environmental influences. Inflammatory reactions in AR are regulated by many cytokines. The impact of genetic factors on the pathogenesis of AR is currently an area of intense investigation. Various loci and candidate genes have been suggested to underlie allergy. Many or all are still controversial. No significant evidence for linkage to AR has been shown so far, although significant evidence for linkage to various allergic diseases. The aim of this review was to investigate whether the genetic polymorphisms were associated with AR in the literature.
Export Options
About this article
Cite this article as:
Vayisoglu Yusuf and Unal Murat, Genetic Polymorphism in Allergic Rhinitis, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2008; 7 (1) . https://dx.doi.org/10.2174/187152308783769195
DOI https://dx.doi.org/10.2174/187152308783769195 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Endogenous Retroelements in Cellular Senescence and Related Pathogenic Processes: Promising Drug Targets in Age-Related Diseases
Current Drug Targets Lipases and their Applications in Biomedical Field
Current Biotechnology Novel Genetic and Peptide-Based Strategies Targeting the Bcl-2 Family, an Update
Recent Patents on DNA & Gene Sequences The Co-regulatory Role of 5-Lipoxygenase and Cyclooxygenase-2 in the Carcinogenesis and their Promotion by Cigarette Smoking in Colons
Current Medicinal Chemistry Mouse Models of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Current Pharmaceutical Design Review of Theoretical Studies for Prediction of Neurodegenerative Inhibitors
Mini-Reviews in Medicinal Chemistry Magnitude and Clinical Profile of Juvenile Idiopathic Arthritis in a Medical College Hospital of a Socio-economically Disadvantaged Country
Current Rheumatology Reviews Current and Future Treatment Options in Idiopathic Pulmonary Fibrosis
Inflammation & Allergy - Drug Targets (Discontinued) Nalmefene: A Novel Drug for an Old Disorder
Current Medicinal Chemistry IFN-γ and TNF-α Gene Polymorphisms in Multiple Sclerosis Patients in Northwest Iran
Endocrine, Metabolic & Immune Disorders - Drug Targets Lifestyle Changes and Pharmacological Risk Factor Modification for Effective Vascular Disease Prevention
Vascular Disease Prevention (Discontinued) Ebola Virus Altered Innate and Adaptive Immune Response Signalling Pathways: Implications for Novel Therapeutic Approaches
Infectious Disorders - Drug Targets Borderline Personality Disorder and Oxytocin: Review of Clinical Trials and Future Directions
Current Pharmaceutical Design Molecular Response to Hypericin-Induced Photodamage
Current Medicinal Chemistry Leptin, Ciliary Neurotrophic Factor, Leukemia Inhibitory Factor and Interleukin- 6: Class-I Cytokines Involved in the Neuroendocrine Regulation of the Reproductive Function
Current Protein & Peptide Science Cell Surface Nucleolin as a Target for Anti-Cancer Therapies
Recent Patents on Anti-Cancer Drug Discovery Novel PET Tracers in the Management of Cardiac Sarcoidosis
Current Radiopharmaceuticals Recent Progress of Novel Steroid Derivatives and Their Potential Biological Properties
Mini-Reviews in Medicinal Chemistry Therapeutic Targeting of B Lymphocyte Stimulator (BLyS) in the Rheumatic Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Adrenomedullin as a Potential Therapeutic Agent for Inflammatory Bowel Disease
Current Protein & Peptide Science